The University Of Texas Health Science Center At San Antonio

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Expanded Access to Everolimus, for an Individual Patient With GIST (Gastrointestinal Stromal Tumors)(CTMS#18-0019)

First Posted Date
2018-04-10
Last Posted Date
2024-07-05
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Registration Number
NCT03493152

Expanded Access to Everolimus, for an Individual Patient With Uterine Sarcoma (CTMS#18-0020)

Conditions
Uterine Sarcoma
First Posted Date
2018-04-10
Last Posted Date
2023-12-01
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Registration Number
NCT03493165

Study of Roflumilast in Combination With Standard Chemotherapy for High-risk Diffuse Large B-cell Lymphoma

Phase 1
Completed
Conditions
Lymphoma, B-Cell
Interventions
Drug: Roflumilast
First Posted Date
2018-03-08
Last Posted Date
2024-02-21
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Target Recruit Count
14
Registration Number
NCT03458546
Locations
🇺🇸

Mays Cancer Center, UT Health San Antonio, San Antonio, Texas, United States

Impact of Exercise on Prognostic Biomarkers Related to Prostate Cancer

Not Applicable
Completed
Conditions
Prostatic Neoplasm
Interventions
Other: Home-Based Exercise Program
First Posted Date
2018-01-11
Last Posted Date
2021-08-10
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Target Recruit Count
27
Registration Number
NCT03397030
Locations
🇺🇸

South Texas Veterans Health Care, San Antonio, Texas, United States

🇺🇸

UT Health San Antonio School of Nursing, San Antonio, Texas, United States

Can Exenatide Prevent Increase in EGP in Response to Dapagliflozin-induced Increase in Glucosuria

First Posted Date
2017-11-06
Last Posted Date
2023-07-24
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Target Recruit Count
107
Registration Number
NCT03331289
Locations
🇺🇸

University Health System Texas Diabetic Institute, San Antonio, Texas, United States

Breast/Evaluation of Cryotherapy and TRPA1 Receptors in Chemotherapy Induced Neuropathy

Not Applicable
Completed
Conditions
Peripheral Neuropathies
Interventions
Device: Cryotherapy
First Posted Date
2017-11-01
Last Posted Date
2024-10-16
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Target Recruit Count
12
Registration Number
NCT03329131
Locations
🇺🇸

UT Health Cancer Center, San Antonio, Texas, United States

Radiographic and the Esthetic Outcome of Two Different Bone Grafting Techniques in Early Implant Placement

First Posted Date
2017-10-04
Last Posted Date
2017-10-04
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Target Recruit Count
48
Registration Number
NCT03302143

Secondary Prevention Trial of Rapamycin in Patients With Resected Non-muscle Invasive Bladder Cancer

Phase 3
Withdrawn
Conditions
Bladder Cancer
Interventions
Drug: Rapamycin
Drug: Placebo Oral Tablet
First Posted Date
2017-10-02
Last Posted Date
2019-06-12
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Registration Number
NCT03298958
Locations
🇺🇸

University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

Empagliflozin and Hepatic Glucose Metabolism

First Posted Date
2017-06-21
Last Posted Date
2024-08-28
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Target Recruit Count
72
Registration Number
NCT03193684
Locations
🇺🇸

Diabetes Division, UTHSCSA, San Antonio, Texas, United States

Ridge Preservation Using FDBA and a Collagen Wound Dressing in Molar Sites

First Posted Date
2017-06-19
Last Posted Date
2018-04-09
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Target Recruit Count
27
Registration Number
NCT03191448
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy